نتایج جستجو برای: پارومومایسین paromomycin

تعداد نتایج: 485  

2012
Raquel García-Hernández José Ignacio Manzano Santiago Castanys Francisco Gamarro

Drug combinations for the treatment of leishmaniasis represent a promising and challenging chemotherapeutic strategy that has recently been implemented in different endemic areas. However, the vast majority of studies undertaken to date have ignored the potential risk that Leishmania parasites could develop resistance to the different drugs used in such combinations. As a result, this study was...

Journal: :Advanced pharmaceutical bulletin 2014
Elnaz Mehdizadeh Aghdam Abolfazl Barzegar Mohammad Saeid Hejazi

PURPOSE Riboswitches, as noncoding RNA sequences, control gene expression through direct ligand binding. Sporadic reports on the structural relation of riboswitches with ribosomal RNAs (rRNA), raises an interest in possible similarity between riboswitches and rRNAs evolutionary origins. Since aminoglycoside antibiotics affect microbial cells through binding to functional sites of the bacterial ...

Journal: :The Journal of antimicrobial chemotherapy 2012
Sushmita Das Mukta Rani Krishna Pandey Ganesh Chandra Sahoo Vidya Nand Rabidas Dharmendra Singh Pradeep Das

OBJECTIVES To evaluate the in vitro activity of antileishmanial drugs, paromomycin and miltefosine, to generate Th-1-biased immunomodulation in hosts against intracellular Leishmania donovani. METHODS In silico protein-ligand interaction and in vitro drug-cell interaction assays were performed. Interaction assays of TLR4-deficient HEK293 cells and HEK293 cells engineered to express either TLR...

2017
Ridwanur Rahman Vishal Goyal Rashidul Haque Kazi Jamil Abul Faiz Rasheda Samad Sally Ellis Manica Balasegaram Margriet den Boer Suman Rijal Nathalie Strub-Wourgaft Fabiana Alves Jorge Alvar Bhawna Sharma

BACKGROUND AmBisome therapy for VL has an excellent efficacy and safety profile and has been adopted as a first-line regimen in Bangladesh. Second-line treatment options are limited and should preferably be given in short course combinations in order to prevent the development of resistant strains. Combination regimens including AmBisome, paromomycin and miltefosine have proved to be safe and e...

Journal: :Lancet 2011
Shyam Sundar Prabhat Kumar Sinha Madhukar Rai Deepak Kumar Verma Kumar Nawin Shanawwaj Alam Jaya Chakravarty Michel Vaillant Neena Verma Krishna Pandey Poonam Kumari Chandra Shekhar Lal Rakesh Arora Bhawna Sharma Sally Ellis Nathalie Strub-Wourgaft Manica Balasegaram Piero Olliaro Pradeep Das Farrokh Modabber

BACKGROUND Improved treatment approaches are needed for visceral leishmaniasis. We assessed the efficacy and safety of three potential short-course combination treatments compared with the standard monotherapy in India. METHODS Standard treatment (1 mg/kg amphotericin B infusion on alternate days for 30 days, total dose 15 mg/kg) was compared with three drug combinations (single injection of ...

2012
Viroj Wiwanitkit

Leishmaniasis is an important vector-borne disease, and it is classified as one of the most important tropical fly-borne infections. This disease can cause two types of clinical manifestations: cutaneous forms and visceral forms. Visceral leishmaniasis, which is also called kala-azar, is a very serious infection that can be fatal. The management of visceral leishmaniasis requires informed diagn...

2010
Partha Santanam Fritz H. Kayser Eli Lilly

Certain strains of Staphylococcus epidermidis resistant to the aminoglycoside antibiotics were shown to contain an enzyme that inactivates the kanamycins, neomycins, butirosins, paromomycin, gentamicin A, amikacin, and tobramycin by adenylylation. Tobramycin adenylyltransferase, as this enzyme is called, was found to be optimally active at pH 5.5. With paromomycin or neomycin Band C as substrat...

2010
Ying Liu Shaorui Hou Liping Wang Shuxian Yang

Paromomycin (PARO, synonym: aminosidine, Figure 1), a broad spectrum aminoglycoside antibiotic first isolated in 1956 from the fermentation of streptomyces[1], shows activity against both grampositive and gram-negative bacteria as well as some protozoa and cestodes. Although it is not used as an antibiotic any more, paromomycin has been approved since 2007 in India as an effective, well tolerat...

Journal: :Antimicrobial agents and chemotherapy 1975
D Loebenberg M Counels J A Waitz

Antibiotic G-418 was shown to be superior to paromomycin and metronidazole in cecal amoebiasis. Of particular interest was the high degree of activity seen with a relatively short treatment at low levels. Although the antibiotic was trichomonacidal in vitro at low levels, in vivo results indicated that at levels tested the antibiotic did not always affect cures. The antibiotic appears to have p...

Journal: :jundishapur journal of natural pharmaceutical products 0
heibatullah kalantari toxicology research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; center medicinal plants research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran ali asghar hemmati department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; physiology research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran neda bavarsad nanotechnology research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; department of pharmaceutics, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran annahita rezaie department of pathobiology, faculty of veterinary medicine, shahid chamran university of ahvaz, ahvaz, ir iran shahin ahmadi department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran. tel: +98-9306282096

conclusions in general, it can be said that the application of nanoliposomal paromomycin sulfate formulations for topical treatment of the cutaneous leishmaniasis does not create serious side effects in the short term, but its long-term use leads to mild renal and liver side effects that requires more attention. background hepatotoxicity due to drugs is the most common cause of deaths. nephroto...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید